Navigation Links
Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer
Date:8/4/2008

/CAUTION -- ADVANCE FOR RELEASE AT 5 P.M. EDT MONDAY, AUG. 4/

/ADVANCE/ ROCKVILLE, Md., Aug. 4 -- Men age 75 and older should not be screened for prostate cancer, and younger men should discuss the benefits and harms of the prostate-specific antigen (PSA) test with their clinicians before being tested, according to a new recommendation from the U.S. Preventive Services Task Force. The recommendation and accompanying evidence summary appear in the August 5 issue of the Annals of Internal Medicine.

The Task Force found evidence that screening for prostate cancer provided few health benefits but led to substantial physical harms and some psychological harms in men age 75 and older. In men younger than 75, the Task Force concluded that current evidence is insufficient to assess the balance of benefits and harms of prostate cancer screening. An estimated 218,890 U.S. men were diagnosed with prostate cancer in 2007, and one in six men will be diagnosed in his lifetime.

Screening for prostate cancer is most often performed using PSA tests and digital rectal exams. The PSA test is more likely to detect prostate cancer than the digital rectal exam. However, prostate cancers that are found with a PSA test take years to affect health; most prostate cancers that grow serious enough to cause death take more than 10 years to do so. Since a 75-year-old man has an average life expectancy of about 10 years and is more likely to die from other causes such as heart disease or stroke, prostate cancer screening is unlikely to help men over 75 live longer.

For the same reasons, men younger than 75 with chronic medical problems and a life expectancy of fewer than 10 years are also unlikely to benefit from screening. There are also harms associated with prostate cancer screening, which include biopsies, unnecessary treatment and false-positive results that may lead to anxiety. Complications often result from treating prostate cancer and may include urinar
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Secretary Reinforces VAs Commitment to Research Safety and Veteran Focus
2. Task Force Recommends Screening for Hearing Loss in All Newborns
3. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
4. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
5. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
6. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
7. Mitchell, Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research; Mitchell Endorses Ground Breaking Traumatic Brain Injury Study
8. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
9. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
10. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
11. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014  The management team at Columbia Laboratories, ... a conference call on July 31, 2014, to ... June 30, 2014.  The call details are as ... am EDTDial-in numbers: , Toll free: (877) 870-4263 ... & archive): , www.columbialabs.com , under ,Investor, ...
(Date:7/23/2014)...  Silk Road Medical, Inc., a developer of ... and extra-cranial cerebrovascular disease, announced today the appointment ... position of Chief Technology Officer.  In this new ... Development efforts across its family of transcarotid access ... joining Silk Road Medical, Michael was the Vice ...
(Date:7/23/2014)... July 23, 2014  Dompe, a leader in R&D for ... that rhNGF (Recombinant Human Nerve Growth Factor) has been designated ... Administration (FDA). The candidate drug, developed by ... drug for the treatment of neurotrophic keratitis, a degenerative corneal ... and is currently without a cure. This is the ...
Breaking Medicine Technology:Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4
... N.C., July 27 Timothy Mastro,MD, FACP, DTM&H, ... 1st,as Senior Director of Research, will share information ... prevention at the,International AIDS Conference in Mexico City., ... Planned Trials," will examine ongoing and upcoming clinical ...
... BIRMINGHAM, Ala., July 28 BioCryst,Pharmaceuticals, Inc. (Nasdaq: ... Phase II study of intravenous (i.v.) peramivir administered ... for the treatment of seasonal,influenza. The trial, conducted ... met its primary endpoint of improvement in the ...
Cached Medicine Technology:HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference 2BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 2BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 3BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 4BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 5
(Date:7/23/2014)... July 23, 2014 (HealthDay News) -- Regularly checking the ... stroke, researchers report. "Screening pulse is the method ... over age 65 who have never had a stroke. ... noninvasive and easy way to identify people who might ... said study author Dr. Bernd Kallmunzer, of Erlangen University ...
(Date:7/23/2014)... Officials from China,s Northwest Agricultural and Forestry University in ... signed a memorandum of agreement that lays the groundwork ... Safety in China. , The signing ceremony was held ... between high-level officials of the U.S. Department of Agriculture ... agreement is a landmark event for UC Davis and ...
(Date:7/23/2014)... Coral, FL (PRWEB) July 23, 2014 Rich ... announce the success of their charity yard sale to support ... was raised and 100% of the proceeds will be donated ... at the event are being donated to the Habitat for ... Fort Myers, Florida 33903. , One of the highlights ...
(Date:7/23/2014)... 23, 2014 Global Cardio Care, Inc., ... External Counterpulsation (EECP), is celebrating the 100th birthday ... at the health center. , Weber has been ... receiving ongoing EECP therapy since 1999, he no longer ... CEO of Global Cardio Care, introduced the Sara ...
(Date:7/23/2014)... 23, 2014 Bodybuilding.com, the Internet’s most-visited ... of nutritional supplements, has officially opened the polls for ... , the fastest growing sports nutrition company, is up ... of the Year, Best Tasting Protein of the Year- ... of the year - Whey-HD™, Pre-workout Supplement of the ...
Breaking Medicine News(10 mins):Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:Rich Dad Education Charity Yard Sale Raises Over $650 for Habitat for Humanity of Lee and Hendry Counties 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3
... born children can also lead normal lives in a ... the McMaster University’s Saroj Saigal. Where educational achievements are ... who were born prematurely, and those with a normal ... greater risk of problems in behavior and academic achievement. ...
... a person was used as a basis to judge the ... report published in the Journal of the American Medical Association. ... that of their Indian and White compatriots, where HIV and ... said to have been implemented by the South African National ...
... failure following use of the drug aprotinin, marketed as ... the drug in heart surgery patients.// The clotting drug ... undergoing cardiac surgery. ,It has now been ... were twice as likely to develop kidney failure and ...
... Global Health Program, founded by Bill and Melinda Gates, ... Executive Director, according to the Gates foundation Release. Dr ... GlaxoSmithKline, will now lead the program. ,Yamada’s key ... while also working on enhancing the availability of drugs ...
... of Medical Research, Sydney have expressed hope over their ... rheumatoid arthritis. //It is also claimed to improve the ... attack, sepsis, psoriasis and post transplant recipients. ... models (mice) and promising results have been obtained. It ...
... unscientific fears, according to a skier who is on a ... a report which states that second hand smoke (SHS) does ... smokers consider the measures as attempts by the powerful antismoking ... ,The Utah Legislature is bei9ng called upon to counter ...
Cached Medicine News:Health News:Safety Of Heart Drug Questioned 2
... The only portable 36/70 static/kinetic/multi-color perimeter that ... room and costs only slightly more than ... perimeter,The Centerfield automatically performs static and kinetic ... to 70 with a fixation shift. Offers ...
... Wavefront Analyzer provides the practitioner with ... analysis system on the market today! ... auto refractometer, auto keratometer, and a ... benefits of wavefront measurement!, ,The KR-9000PW ...
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
Medicine Products: